Azurity Pharmaceuticals, Inc. announced that ARYNTA(TM) (lisdexamfetamine dimesylate) Oral Solution is now available in the United States for treating ADHD in adults and pediatric patients 6 years and ...
PARAMUS, N.J., April 6, 2026 /PRNewswire/ -- SK Life Science, Inc., a U.S. subsidiary of SK Biopharmaceuticals Co., Ltd., today announced that it will present multiple posters at the American Academy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results